Abstract
Purpose
The first Argentine experience with epidemiologic, molecular, and genetic counseling data is reported.
Methods
We analyzed 43 families fulfilling Amsterdam criteria identified from a prospective database with data from 779 relatives.
Results
Eleven families (25.6 percent) presented as Lynch I, 29 (67.4 percent) as Lynch II, and 3 (7 percent) as Muir-Torre syndrome. Among the 306 affected members, 197 cases of colorectal cancer were identified (mean age at diagnosis, 52.1 (range, 21–90) years). The most frequent extracolonic tumors were gastric adenocarcinoma in males and endometrium adenocarcinoma in females. A high incidence of breast cancer was observed (16 cases among 155 females, crude rate: 11,594.20/100,000). Twenty-seven patients (8.8 percent) developed more than one tumor. These patients were younger than those with only one tumor (45 vs. 51 years; P = 0.001). In 5 of 11 patients who underwent molecular sequencing, a pathologic mutation was found. A novel C deletion at 1910 nucleotide, codon 637, exon 12 of MSH2 gene was identified in a family with a strong aggregation of breast cancer with lack of MSH2 immunohistochemical staining. For 78.2 percent of counseled individuals, this session represented the first time they received information, and 73.9 percent stated that their physicians were unaware of their family background.
Conclusions
Argentine families presented a high incidence of stomach cancer. The elevated incidence of breast cancer and its association with a novel hMSH2 mutation bring to consideration the inclusion of this malignancy as part of the syndrome. A lack of awareness by both physicians and persons at risk was observed.
Similar content being viewed by others
References
Voskuil DW, Vasen H, Kampman E, van’t Veer P. Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations. Int J Cancer 1997;72:205–9.
Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition: Update of ICG-HNPCC-INSiGHT mutation database. Dis Markers 2004;20:269–76.
Wijnen J, de Leeuw W, Vasen H, et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 1999;23:142–4.
Lynch HT, Lynch JF. The Lynch syndromes. Curr Opin Oncol 1993;5:687–96.
Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum and larynx associated with kerato-acanthoma of the face. Br J Surg 1967;54:191–5.
Torre D. Multiple sebaceous tumors. Arch Dermatol 1968;98:549–51.
Zhang YZ, Sheng JQ, Li SR, Zhang H. Clinical phenotype and prevalence of hereditary nonpolyposis colorectal cancer syndrome in Chinese population. World J Gastroenterol 2005;11:1481–8.
Rossi BM, Lopes A, Oliveira Ferreira F, et al. hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 2002;9:555–61.
Rossi BM, Corvello CM, Epelman M, et al. Hereditary colorectal tumors: routine care and the multidisciplinary therapeutic approach. S Am J Cancer 1997;1:191–7.
Ferreira Oliveira F, Ferreira Napoli CC, Rossi BM, et al. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families. Fam Cancer 2004;3:41–7.
Sarroca C, Peltomaki P, Alfano N, et al. Three new mutations in hereditary nonpolyposis colorectal cancer (Lynch II) in Uruguay. Cancer Genet Cytogenet 2003;142:13–20.
Sarroca C, Valle AD, Fresco R, Renkonen R, Peltomaki P, Lynch H. Frequency of hereditary non-polyposis colorectal cancer in Uruguayan patients with colorectal cancer. Clin Genet 2005;68:80–7.
Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424–5.
Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999;116:1453–6.
Renkonen E, Zhang Y, Lohi H, et al. Altered expression of MLH1, MSH2 and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 2003;21:3629–37.
Muller W, Burgart LJ, Krause-Paulus R, et al. The reliability of inmunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) - results of an international collaborative study. Fam Cancer 2001;1:87–92.
Boland CR, Thibodeau SN, Hamilton SR, et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248–57.
Church J, Kiringoda R, LaGuardia L. Inherited colorectal cancer registries in the United States: the state of the union. Dis Colon Rectum 2004;47:674–8.
Rodriguez-Bigas MA, Lee PH, O’Malley L, et al. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 1996;39:649–53.
Fitzgibbons RJ Jr, Lynch HT, Stanislav GV, et al. Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). Ann Surg 1987;206:289–95.
Goecke T, Schulmann K, Engel C, et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 2006;24:4285–92.
Mangold E, Pagesntecher C, Leister M, et al. A genotype-phenotype correlation in HNPCC: strong predominance of MSH2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet 2004;41:567–72.
Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005;293:1979–85.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Vaccaro, C.A., Bonadeo, F., Roverano, A.V. et al. Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register. Dis Colon Rectum 50, 1604–1611 (2007). https://doi.org/10.1007/s10350-007-9037-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-007-9037-y